INSMED INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
INSMED INC (INSM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.36 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-19
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-12-31 was 145.59K shares, a 88.30% increase year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 179.81K shares, a 102.60% increase year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-30 was 107.85K shares, a 90.85% decline year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-03-31 was 1.32M shares, a 40.67% increase year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.36M shares, a 72.57% decline from fiscal 2024.
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 4.96M shares, a 25.37% decline from fiscal 2023.
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 6.65M shares, a 18.46% increase from fiscal 2022.
- INSMED INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 5.61M shares, a 38.99% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.36M shares 10-K · filed 2026-02-19 | |||
| 2024-12-31 | 4.96M shares 10-K · filed 2025-02-20 | |||
| 2023-12-31 | 6.65M shares 10-K · filed 2025-02-20 | |||
| 2022-12-31 | 5.61M shares 10-K · filed 2025-02-20 | |||
| 2021-12-31 | 4.04M shares 10-K · filed 2024-02-22 | |||
| 2020-12-31 | 3.99M shares 10-K · filed 2023-02-23 | |||
| 2019-12-31 | 3.43M shares 10-K · filed 2022-02-17 | |||
| 2018-12-31 | 145.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 325.40K shares derived: sum of 2 quarters · filed 2021-02-25 | 433.25K shares derived: sum of 3 quarters · filed 2021-02-25 | 1.76M shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 179.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | 287.66K shares derived: sum of 2 quarters · filed 2018-10-30 | 1.61M shares 10-Q · filed 2018-10-30 | 1.69M shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 107.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 1.43M shares 10-Q · filed 2018-08-02 | 1.51M shares derived: sum of 3 quarters · filed 2020-02-25 | 1.60M shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 1.32M shares 10-Q · filed 2018-05-02 | 1.40M shares derived: sum of 2 quarters · filed 2020-02-25 | 1.49M shares derived: sum of 3 quarters · filed 2020-02-25 | 2.67M shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | 77.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 166.07K shares derived: sum of 2 quarters · filed 2020-02-25 | 1.34M shares derived: sum of 3 quarters · filed 2020-02-25 | 2.28M shares 10-K · filed 2020-02-25 |
| 2017-09-30 | 88.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 1.27M shares derived: sum of 2 quarters · filed 2017-11-02 | 2.21M shares 10-Q · filed 2017-11-02 | 2.33M shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | 1.18M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 2.12M shares 10-Q · filed 2017-08-03 | 2.25M shares derived: sum of 3 quarters · filed 2019-02-22 | 2.33M shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | 940.06K shares 10-Q · filed 2017-05-03 | 1.07M shares derived: sum of 2 quarters · filed 2019-02-22 | 1.16M shares derived: sum of 3 quarters · filed 2019-02-22 | 2.48M shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | 126.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 215.65K shares derived: sum of 2 quarters · filed 2019-02-22 | 1.54M shares derived: sum of 3 quarters · filed 2019-02-22 | 2.53M shares 10-K · filed 2019-02-22 |
| 2016-09-30 | 89.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 1.42M shares derived: sum of 2 quarters · filed 2016-11-03 | 2.41M shares 10-Q · filed 2016-11-03 | 2.57M shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | 1.33M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 2.32M shares 10-Q · filed 2016-08-04 | 2.48M shares derived: sum of 3 quarters · filed 2018-02-23 | 2.54M shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | 988.50K shares 10-Q · filed 2016-05-05 | 1.15M shares derived: sum of 2 quarters · filed 2018-02-23 | 1.21M shares derived: sum of 3 quarters · filed 2018-02-23 | 2.27M shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | 162.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | 218.80K shares derived: sum of 2 quarters · filed 2018-02-23 | 1.28M shares derived: sum of 3 quarters · filed 2018-02-23 | 1.90M shares 10-K · filed 2018-02-23 |
| 2015-09-30 | 56.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 1.12M shares derived: sum of 2 quarters · filed 2015-11-06 | 1.74M shares 10-Q · filed 2015-11-06 | 1.75M shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | 1.06M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 1.68M shares 10-Q · filed 2015-08-06 | 1.69M shares derived: sum of 3 quarters · filed 2017-02-23 | 1.77M shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | 619.15K shares 10-Q · filed 2015-05-07 | 626.75K shares derived: sum of 2 quarters · filed 2017-02-23 | 702.25K shares derived: sum of 3 quarters · filed 2017-02-23 | 1.57M shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | 7.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 83.10K shares derived: sum of 2 quarters · filed 2017-02-23 | 951.40K shares derived: sum of 3 quarters · filed 2017-02-23 | 1.60M shares 10-K · filed 2017-02-23 |
| 2014-09-30 | 75.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 943.80K shares derived: sum of 2 quarters · filed 2014-11-06 | 1.59M shares 10-Q · filed 2014-11-06 | 1.93M shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | 868.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | 1.52M shares 10-Q · filed 2014-08-06 | 1.86M shares derived: sum of 3 quarters · filed 2016-02-25 | 2.22M shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | 649.05K shares 10-Q · filed 2014-05-08 | 988.75K shares derived: sum of 2 quarters · filed 2016-02-25 | 1.36M shares derived: sum of 3 quarters · filed 2016-02-25 | 2.42M shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | 339.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 706.40K shares derived: sum of 2 quarters · filed 2016-02-25 | 1.77M shares derived: sum of 3 quarters · filed 2016-02-25 | 2.32M shares 10-K · filed 2016-02-25 |
| 2013-09-30 | 366.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | 1.43M shares derived: sum of 2 quarters · filed 2013-11-05 | 1.98M shares 10-Q · filed 2013-11-05 | 2.17M shares derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | 1.06M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | 1.62M shares 10-Q · filed 2013-08-06 | 1.80M shares derived: sum of 3 quarters · filed 2015-02-27 | 2.71M shares derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | 552.25K shares 10-Q · filed 2013-05-07 | 736.25K shares derived: sum of 2 quarters · filed 2015-02-27 | 1.65M shares derived: sum of 3 quarters · filed 2015-02-27 | |
| 2012-12-31 | 184.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | 1.10M shares derived: sum of 2 quarters · filed 2015-02-27 | 1.12M shares 10-K · filed 2015-02-27 | |
| 2012-09-30 | 913.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | 932.38K shares 10-Q · filed 2012-11-07 | ||
| 2012-06-30 | 18.90K shares 10-Q · filed 2012-08-07 | |||
| 2011-12-31 | 766.00K shares 10-K · filed 2014-03-06 | |||
| 2010-12-31 | 0.00 shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |